PCS-2023: XW0D Introduction, Mouth and Pharynx

PCS-2023 > X > XW > XW0 > XW0D

XW0	Anatomical Regions, Introduction
	Info:	Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
XW0D	Introduction, Mouth and Pharynx
XW0DX	External
XW0DX3	Maribavir Anti-infective
XW0DX38	Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8
XW0DX6	Lefamulin Anti-infective
XW0DX66	Introduction of Lefamulin Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 6
XW0DX8	Uridine Triacetate
XW0DX82	Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2
XW0DXF	Other New Technology Therapeutic Substance
XW0DXF5	Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5
XW0DXJ	Apalutamide Antineoplastic
XW0DXJ5	Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
XW0DXL	Erdafitinib Antineoplastic
XW0DXL5	Introduction of Erdafitinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
XW0DXM	Baricitinib
XW0DXM6	Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6
XW0DXR	Venetoclax Antineoplastic
XW0DXR5	Introduction of Venetoclax Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
XW0DXR7	Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7
XW0DXT	Ruxolitinib
XW0DXT5	Introduction of Ruxolitinib into Mouth and Pharynx, External Approach, New Technology Group 5
XW0DXV	Gilteritinib Antineoplastic
XW0DXV5	Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5

and

Anatomical Regions, Introduction

Introduction, Mouth and Pharynx